Delivery Order SPE2DB22D3010-SPE2DB23FP2AJ

Award Date 4/27/23
Potential Completion Date 4/28/23
Potential Value $15K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $4,936.29 and a completion date of May 7, 2024. The contract is a Firm Fixed Price, Delivery Order type, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has several...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The contract, with a ceiling value of $3,746.26, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a final completion date of November 20, 2023. This contract was awarded on an unrestricted, full and open competition basis, with no set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract, valued at $10,948.23, has a firm fixed price and is set to expire on November 7, 2023. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used for diabetes management. The contract has a ceiling value of $1,741.68 and an ultimate completion date of April 23, 2024. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order awarded by the Defense Logistics Agency (DLA) for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $2,876.16 and an ultimate completion date of October 29, 2021. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,077.98, is for the delivery of 4562731140 TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a period of performance through November 7, 2023 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $6,996.24 and an ultimate completion date of October 18, 2023. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as a major...
This is a delivery order with a firm fixed price contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $10,631.64 and an ultimate completion date of August 17, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $10,554.20 for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a performance period through May 11, 2023. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $6,549.68 and a completion date of April 14, 2023. This award is not associated with a set-aside program. The contract is a firm fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB23FP2AJ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $14,513.89. The contract has a period of performance through April 28, 2023 and is a firm fixed-price delivery order.

Amerisourcebergen Drug Corp holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00 respectively. These IDCs enable the company to efficiently deliver a comprehensive range of pharmaceutical products and medical supplies to support various federal healthcare programs, including those serving the Department of Defense, military treatment facilities, and veterans' healthcare systems. The contract award reviewed did not have a set-aside designation, indicating open competition.

Generated 5/9/25, 10:17 AM